Atlas Oncology Partners
PrivateLast Round
Series A
Feb 25, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atlas Oncology Partners is a healthcare services company that provides a value-based oncology enablement platform by embedding interdisciplinary care teams into community oncology practices and assuming full medical cost risk.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Oncology Partners Comparables
Compare Atlas Oncology Partners with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thyme Care | 80% | |
| Cencora | 74% | |
| Evolent Health | 71% | |
Atlas Oncology Partners Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 25, 2026 |
Atlas Oncology Partners Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flare Capital Partners | Series A |
| Rubicon Founders | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles increased to 14, 93% of headcount.
- Aug 24, 2026
Grew 36% QoQ from 11 to 15 employees.
Atlas Oncology Partners Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |